908 Devices (NASDAQ:MASS) Director Christopher Brown Sells 8,358 Shares of Stock

908 Devices Inc. (NASDAQ:MASS) Director Christopher Brown sold 8,358 shares of 908 Devices stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $9.23, for a total value of $77,144.34. Following the completion of the sale, the director directly owned 805,559 shares in the company, valued at $7,435,309.57. This represents a 1.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Price Performance

MASS stock opened at $10.02 on Thursday. The stock has a market capitalization of $378.86 million, a P/E ratio of -10.55 and a beta of 0.66. The business has a 50-day moving average of $8.26 and a 200-day moving average of $7.36. 908 Devices Inc. has a fifty-two week low of $5.03 and a fifty-two week high of $10.52.

908 Devices (NASDAQ:MASS) last announced its earnings results on Tuesday, August 11th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.03. The business had revenue of $16.07 million for the quarter, compared to analyst estimates of $15.37 million. 908 Devices had a negative return on equity of 12.29% and a negative net margin of 56.96%. Equities analysts expect that 908 Devices Inc. will post -0.4 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. First Light Asset Management LLC boosted its holdings in shares of 908 Devices by 25.6% during the first quarter. First Light Asset Management LLC now owns 6,072,563 shares of the company’s stock worth $37,164,000 after acquiring an additional 1,236,377 shares during the period. ARK Investment Management LLC lifted its holdings in 908 Devices by 1.6% during the 4th quarter. ARK Investment Management LLC now owns 1,985,986 shares of the company’s stock worth $10,426,000 after purchasing an additional 32,214 shares during the last quarter. BlackRock Inc. bought a new stake in 908 Devices in the 2nd quarter valued at $16,915,000. Needham Investment Management LLC grew its holdings in 908 Devices by 246.8% in the 4th quarter. Needham Investment Management LLC now owns 770,000 shares of the company’s stock valued at $4,042,000 after buying an additional 548,000 shares in the last quarter. Finally, Granahan Investment Management LLC increased its position in 908 Devices by 662.6% during the 1st quarter. Granahan Investment Management LLC now owns 695,070 shares of the company’s stock worth $4,254,000 after buying an additional 603,929 shares during the period. 88.06% of the stock is owned by institutional investors.

Key Headlines Impacting 908 Devices

Here are the key news stories impacting 908 Devices this week:

• Positive Sentiment: Q2 earnings and revenue exceeded expectations. 908 Devices reported a loss of $0.11 per share, better than the $0.14 consensus loss, while revenue reached $16.07 million versus estimates of $15.37 million. Revenue increased 23% year over year, and the company said its adjusted EBITDA loss narrowed by more than half from the prior year. 908 Devices Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Management raised the low end of its full-year outlook. 908 Devices now expects 2026 revenue of $68 million to $70 million, compared with the previous outlook’s lower starting point and roughly in line with the $68.6 million analyst consensus. The company’s guidance excludes potential AVCAD contribution from its core outlook, which may leave room for upside if that business contributes. 908 Devices Signals 2026 Revenue Outlook
• Positive Sentiment: Growth drivers remain intact. Demand for chemical-detection instruments from law enforcement, defense, and other mission-critical customers, along with recurring NIRLab revenue and upgrades such as VipIR, is supporting the bullish view. One analyst publication maintained a BUY rating after the earnings beat. 908 Devices Mission Critical Devices Drive Growth
• Neutral Sentiment: 908 Devices plans to present at the 17th Annual Midwest IDEAS Investor Conference, providing an opportunity for management to discuss its outlook and growth strategy. 908 Devices to Present at the Midwest IDEAS Investor Conference
• Negative Sentiment: Director Christopher D. Brown sold a combined 17,800 shares for approximately $162,000 across August 10 and 11. The sales were conducted under a pre-arranged Rule 10b5-1 plan, reducing their negative signaling value, and Brown still owns 805,559 shares after the transactions. 908 Devices SEC Insider Trading Filing

Analysts Set New Price Targets

A number of analysts have recently commented on MASS shares. Roth Capital boosted their price objective on shares of 908 Devices from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday. Wall Street Zen lowered shares of 908 Devices from a “buy” rating to a “hold” rating in a research note on Saturday, July 18th. Weiss Ratings reissued a “sell (d-)” rating on shares of 908 Devices in a research report on Friday, August 7th. Finally, Stifel Nicolaus raised their price objective on 908 Devices from $10.00 to $12.00 and gave the company a “buy” rating in a research report on Wednesday. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $12.50.

About 908 Devices

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.